PARSOL® Shield: Next-Generation Sunscreen Protection
PARSOL® Shield (Bemotrizinol) is a breakthrough in sun protection, providing powerful, broad-spectrum UVA and UVB coverage. Known for its high photostability and effective protection at low concentrations, this filter has been widely used internationally for over 20 years, offering trusted protection in Europe, Asia, and Australia. Now, it’s on the path to potential approval in the U.S., marking a significant milestone in sun protection technology.
Benefits of PARSOL® Shield
- Broad-Spectrum Protection: Offers both UVA and UVB protection, minimizing sun damage that leads to premature aging and skin cancers.
- Photostable Formula: PARSOL® Shield retains its protective properties under sunlight, ensuring long-lasting efficacy throughout the day.
- Compatibility: Works well with both organic and inorganic sunscreen ingredients, enhancing formulations without compromising their performance.
Why PARSOL® Shield Matters
PARSOL® Shield’s unique formulation allows for less visible residue, making it suitable for a variety of skin tones and types. Its potential U.S. approval could provide American consumers access to advanced sun protection, contributing to better skin cancer prevention and public health efforts.
Ongoing FDA Review
The FDA is currently reviewing PARSOL® Shield’s safety and efficacy under its updated Over-the-Counter (OTC) sunscreen monograph standards, with a decision anticipated by early 2026. If approved, PARSOL® Shield will be the first new active ingredient added to U.S. sunscreens in over two decades.
Once approved, PARSOL® Shield will be available in various sunscreen products across the U.S., allowing consumers to experience its enhanced protection and skin compatibility benefits firsthand.